Hua Medicine (02552) published its monthly return on movements in securities for the period ended 31 January 2026. Authorized share capital remained 2,000,000,000 ordinary shares at a par value of US$0.001 each, maintaining a total of US$2,000,000. The number of issued shares was unchanged at 1,056,605,016, with no treasury shares recorded.

According to the announcement, public float requirements continue to be met, with the applicable threshold set at 25%. Under the Post-IPO Share Option Scheme, 79,239,669 share options were outstanding at the end of January 2026, with no new exercises, cancellations, or lapses reported. The company confirms that all relevant regulations and listing requirements have been observed throughout the month.